MedPath

Evaluation of the effect of Barley extract in the treatment of chronic urticaria

Phase 2
Recruiting
Conditions
urticaria.
Urticaria
Registration Number
IRCT20210309050643N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Patients with chronic spontaneous urticaria, aged 18 to 60 years
do not have autoimmune disease or immunodeficiency
wish to participate in the study

Exclusion Criteria

pregnancy
Previous hypersensitivity to the drug or any of the compounds present in the herbal medicinal product

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detect the effect of barley extract on clinical symptoms of CSU patients. Timepoint: At the beginning of the intervention and 4 weeks after taking the drug. Method of measurement: International Urticaria Registration Questionnaire.
Secondary Outcome Measures
NameTimeMethod
rticaria clinical symptoms score. Timepoint: At the beginning of the intervention and 4 weeks later. Method of measurement: Urticaria Activity score Questionnaire.;Quality of life of chronic urticaria patients. Timepoint: At the beginning of the intervention and 4 weeks later. Method of measurement: score of Chronic Urticaria Quality of Life questionnaire.;Relapse of patients' clinical symptoms. Timepoint: At the beginning of the intervention and 4 weeks later. Method of measurement: Urticaria Control Test.
© Copyright 2025. All Rights Reserved by MedPath